The Japan Science and Technology Agency (JST) is implementing a funding mechanism for international collaborative research on the theme of the new coronavirus disease (COVID-19) and current pandemic as part of its J-RAPID program. In this mechanism, funding is envisaged for researchers who are currently in collaboration with or anticipate collaboration with researchers whom are funded or anticipate to be funded by eligible foreign funding agencies, such as through the RAPID program of the National Science Foundation (NSF) of the United States, for research directly applicable to mitigation of the ongoing COVID-19 outbreak.

♦ URL: https://www.jst.go.jp/inter/sicorp/download/announce_rapid_7th/eng_guidelines.pdf
 

  • Eligibility
    Funding is available to researchers affiliated with universities, research institutions, corporations and other eligible entities based in Japan.
     
  • Scope
    This program welcomes non-medical research related to the prevention and mitigation of effects of the COVID-19 pandemic conducted jointly with researchers supported by eligible foreign funding agencies. Japan-based researchers must either currently collaborate with, or anticipate to collaborate with, researchers based in foreign research institutions supported by eligible foreign funding agencies.
     
  • Forms of support
    Each successful proposal funded under the J-RAPID program will sign a contract with JST and be awarded between 3 to 6 million Japanese yen, including 10% indirect costs, to cover a research period ranging from six months to one year. The amount of funding awarded is determined based on an assessment of the content of the proposed research, including budgetary requirements, as well as the total number of awarded projects in the program.  
     
  • Deadline
    Thursday, May 21, 2020 at noon, Japan time (tentative)
     
  • Inquiries
    Japan Science and Technology Agency (JST)
    Department of International Affairs
    Mr. HIGUCHI Masayoshi, Mr. Oscar A. Rudenstam
    TEL: +81-3-5214-7375  FAX: +81-3-5214-7379
    E-mail:
    (Email is preferred.)